cetuximab
merck,nanobiotix,eli lilly
['nanoray-312', 'pivotal', 'nanobiotix']
4/4 a pivotal randomized phase iii study titled nanoray-312 is now recruiting in europe the first patient injected was in january. are you interested in learning more about this ongoing phase 3 study? please visit: #asco22 #asco
We design and develop physics-based, disruptive medical innovations to improve outcomes for cancer patients around the world